What are the diagnostic criteria for DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DRESS Syndrome Diagnostic Criteria

DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is diagnosed using the RegiSCAR scoring system, which classifies cases as "no," "possible," "probable," or "definite" based on clinical and laboratory findings. 1

Core Diagnostic Features

  • DRESS syndrome typically presents after a latent period of 2-6 weeks following exposure to the offending drug, which distinguishes it from other drug reactions 2
  • The most common clinical manifestations include:
    • Morbilliform (maculopapular) confluent rash involving >30% of body surface area 2
    • Facial edema 3
    • Fever (>38°C) 4
    • Lymphadenopathy 3
    • Internal organ involvement (liver, kidney, heart, lung) 2, 3

RegiSCAR Diagnostic Criteria

The diagnosis is established through a scoring system based on the following:

  • Cutaneous findings:

    • Maculopapular rash involving >30% of body surface area 2, 5
    • Facial edema 5
  • Systemic involvement:

    • Fever >38°C 4, 5
    • Enlarged lymph nodes (≥2 sites, >1cm) 5, 1
  • Hematologic abnormalities:

    • Eosinophilia (>700/μL or >10% if leukocyte count is abnormal) 5, 1
    • Atypical lymphocytes 5
  • Organ involvement:

    • Liver (ALT >2 times upper limit of normal) 4, 3
    • Kidney (creatinine >1.5 times baseline) 4, 2
    • Lung (pneumonitis, ARDS) 2
    • Heart (myocarditis, pericarditis) 2
  • Other criteria:

    • Exclusion of other causes (infections, autoimmune conditions, malignancy) 5, 1
    • Resolution ≥15 days after drug withdrawal 1

Laboratory Evaluation

  • Complete blood count with differential to assess for:

    • Eosinophilia 4, 5
    • Atypical lymphocytosis 5
    • Leukocytosis 2
  • Comprehensive metabolic panel to evaluate:

    • Liver function (ALT, AST, alkaline phosphatase, bilirubin) 4, 3
    • Kidney function (BUN, creatinine) 4, 2
  • Additional testing:

    • Urinalysis to evaluate for nephritis 4
    • Blood cultures to rule out infectious causes 4
    • Skin biopsy if diagnosis is uncertain 4

Differential Diagnosis

DRESS syndrome must be distinguished from:

  • Other severe cutaneous adverse reactions:

    • Stevens-Johnson Syndrome (SJS) 2
    • Toxic Epidermal Necrolysis (TEN) 2
    • Acute Generalized Exanthematous Pustulosis (AGEP) 2
  • Systemic conditions:

    • Viral infections (particularly herpes family viruses) 2
    • Autoimmune disorders 5
    • Lymphoma 5
    • Hypereosinophilic syndrome 1

Prognostic Indicators

  • Poor prognostic factors include:
    • Eosinophil count >6000 × 10³/μL 5
    • Thrombocytopenia 5
    • Pancytopenia 5
    • Leukocytosis 5
    • Coagulopathy 5
    • Liver failure 6, 3

Common Pitfalls and Caveats

  • Delayed diagnosis is common due to the variable presentation and latency period of 2-6 weeks after drug initiation 2, 5
  • The mortality rate is estimated at 3.8-10%, primarily due to fulminant hepatitis and liver necrosis 5, 6
  • Relapse can occur in approximately 12% of cases, particularly with DRESS associated with viral reactivation 2
  • Certain genetic predispositions (HLA associations) are strongly linked to specific drug reactions, such as HLA-B*58:01 with allopurinol-induced DRESS 7, 2
  • DRESS syndrome must be differentiated from DRESS (Drug Reaction with Eosinophilia and Systemic) syndrome, which is mentioned as a differential diagnosis for other conditions 7

References

Research

The DRESS syndrome: a literature review.

The American journal of medicine, 2011

Guideline

DRESS Syndrome Management and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Hepatitis in the DRESS Syndrome.

GE Portuguese journal of gastroenterology, 2016

Guideline

Treatment of DRESS Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

DRESS syndrome: A literature review and treatment algorithm.

The World Allergy Organization journal, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.